Aesthetic Injectables – Pipeline Products by Stage of Development 15
Aesthetic Injectables – Pipeline Products by Segment 16
Aesthetic Injectables – Pipeline Products by Territory 17
Aesthetic Injectables – Pipeline Products by Regulatory Path 19
Aesthetic Injectables – Pipeline Products by Estimated Approval Date 20
Aesthetic Injectables – Ongoing Clinical Trials 21
Aesthetic Injectables Companies – Pipeline Products by Stage of Development 22
Aesthetic Injectables – Pipeline Products by Stage of Development 25
AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Hyaluronic Acid Filler – Skin – Product Status 28
Hyaluronic Acid Filler – Skin – Product Description 28
Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
ACROFILL – Product Status 29
ACROFILL – Product Description 29
Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Algeness DF – Product Status 30
Algeness DF – Product Description 30
Algeness HD – Product Status 31
Algeness HD – Product Description 31
Algeness LD – Product Status 31
Algeness LD – Product Description 32
Algeness VL – Product Status 32
Algeness VL – Product Description 32
Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 33
Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 34
Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 34
Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
BioDermal Filler – Product Status 35
BioDermal Filler – Product Description 35
Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 36
Alluris – Product Status 36
Alluris – Product Description 36
Skinlumina – Product Status 37
Skinlumina – Product Description 37
SkinTechMD – Product Status 37
SkinTechMD – Product Description 38
Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 39
AAM SubQ Body Filler – Product Status 39
AAM SubQ Body Filler – Product Description 40
ADM Subdermal Body Filler – Product Status 40
ADM Subdermal Body Filler – Product Description 40
Elastagen – Acne Scars – Product Status 40
Elastagen – Acne Scars – Product Description 41
Elastagen – Skin Quality – Product Status 41
Elastagen – Skin Quality – Product Description 41
HA Threads – Product Status 41
HA Threads – Product Description 42
Juvederm – Decolletage – Product Status 42
Juvederm – Decolletage – Product Description 42
Juvederm – Hands – Product Status 42
Juvederm – Hands – Product Description 43
Juvederm – Neck Lines – Product Status 43
Juvederm – Neck Lines – Product Description 43
Juvederm RejuveCross – Deep Wrinkles – Product Status 43
Juvederm RejuveCross – Deep Wrinkles – Product Description 44
Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 44
Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 44
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 44
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 45
Juvederm Voluma – Nose – Product Status 45
Juvederm Voluma – Nose – Product Description 45
Juvederm Voluma – Temple – Product Status 45
Juvederm Voluma – Temple – Product Description 46
Juvederm Voluma Global – Malar Augmentation – Product Status 46
Juvederm Voluma Global – Malar Augmentation – Product Description 46
rhCollagen Dermal Filler – Product Status 46
rhCollagen Dermal Filler – Product Description 47
Allergan Aesthetics – Ongoing Clinical Trials Overview 48
Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 49
Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 49
Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 50
Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Hyaluronic Acid Facial Filler – Product Status 51
Hyaluronic Acid Facial Filler – Product Description 51
Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
Complex Collagen Filler (Type III) – Product Status 52
Complex Collagen Filler (Type III) – Product Description 52
First Generation PLLA Filler (Type III) – Product Status 53
First Generation PLLA Filler (Type III) – Product Description 53
Second Generation PCL Filler (Type III) – Product Status 53
Second Generation PCL Filler (Type III) – Product Description 54
BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Biological Breast – Product Status 55
Biological Breast – Product Description 55
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 56
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 56
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 56
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 57
Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 58
Cytosmile – Product Status 58
Cytosmile – Product Description 58
MTI-12 – Product Status 59
MTI-12 – Product Description 59
MTI-12 – Surgical Repair – Product Status 59
MTI-12 – Surgical Repair – Product Description 60
BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 61
SGA300 – Product Status 61
SGA300 – Product Description 61
SGA302 – Product Status 62
SGA302 – Product Description 62
Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
BMI4002 – Product Status 63
BMI4002 – Product Description 63
CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 64
Lipage – Product Status 64
Lipage – Product Description 64
Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 65
Credurance – Product Status 65
Credurance – Product Description 65
Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
rhCollagen Based Photocurable Regenerative Dermal Filler – Product Status 66
rhCollagen Based Photocurable Regenerative Dermal Filler – Product Description 66
rhCollagen Based Soft Tissue Filler – Product Status 67
rhCollagen Based Soft Tissue Filler – Product Description 67
Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Gouri – Product Status 68
Gouri – Product Description 68
Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
DKB-119 – Product Status 69
DKB-119 – Product Description 69
DKB-133 – Product Status 70
DKB-133 – Product Description 70
DKM-410 – Product Status 70
DKM-410 – Product Description 71
DKM-423 – Product Status 71
DKM-423 – Product Description 71
EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 72
Cellifique – Product Status 72
Cellifique – Product Description 72
Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 73
NCTF 135 – Product Status 73
NCTF 135 – Product Description 73
NCTF 135 HA – Product Status 74
NCTF 135 HA – Product Description 74
G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 75
GB-3001 – Product Status 75
GB-3001 – Product Description 75
Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 76
Biostimulator Filler – Product Status 76
Biostimulator Filler – Product Description 76
Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 77
Prevelle Lift – Product Status 77
Prevelle Lift – Product Description 77
Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
BiOLinkMatrix Gel – Product Status 78
BiOLinkMatrix Gel – Product Description 78
Hyaluronic Acid Dermal Filler – Product Status 79
Hyaluronic Acid Dermal Filler – Product Description 79
Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 80
HST002 – Product Status 80
HST002 – Product Description 80
Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 81
The Chaeum Pure No.1 – Product Status 81
The Chaeum Pure No.1 – Product Description 82
The Chaeum Pure No.2 – Product Status 82
The Chaeum Pure No.2 – Product Description 82
The Chaeum Pure No.3 – Product Status 83
The Chaeum Pure No.3 – Product Description 83
The Chaeum Pure No.4 – Product Status 83
The Chaeum Pure No.4 – Product Description 84
The Chaeum Style – Product Status 84
The Chaeum Style – Product Description 84
Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 85
Wrinkle Filler – Product Status 85
Wrinkle Filler – Product Description 85
inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 86
Fractomer – Product Status 86
Fractomer – Product Description 86
Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 87
IVL-MD-B001 – Product Status 87
IVL-MD-B001 – Product Description 87
IVL-MD-F001 – Product Status 88
IVL-MD-F001 – Product Description 88
IVL-MD-F002 – Product Status 88
IVL-MD-F002 – Product Description 89
Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
HA Filler – Product Status 90
HA Filler – Product Description 90
HA Thread Filler – Product Status 91
HA Thread Filler – Product Description 91
Wool Filler – Product Status 92
Wool Filler – Product Description 92
Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
Tenergel – Product Status 93
Tenergel – Product Description 93
Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 94
Autologous Globin Dermal Filler – Product Status 94
Autologous Globin Dermal Filler – Product Description 94
Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 95
IPN-21-SENSE Dermal Filler – Product Status 95
IPN-21-SENSE Dermal Filler – Product Description 95
Laboratoires Vivacy SAS – Ongoing Clinical Trials Overview 96
IPN-21-SENSE Dermal Filler – A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face 97
LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 98
Dermal Filler (LR19059) – Product Status 98
Dermal Filler (LR19059) – Product Description 98
Dermal Filler (LR19093) – Product Status 99
Dermal Filler (LR19093) – Product Description 99
Hyaluronic Acid Filler (LR19094) – Product Status 99
Hyaluronic Acid Filler (LR19094) – Product Description 99
Hyaluronic Acid Filler (LR20024) – Product Status 100
Hyaluronic Acid Filler (LR20024) – Product Description 100
Next Generation Hyaluronic Acid Filler (LR20008) – Product Status 100
Next Generation Hyaluronic Acid Filler (LR20008) – Product Description 100
YVOIRE Y-Solution 360 – Product Status 101
YVOIRE Y-Solution 360 – Product Description 101
YVOIRE Y-Solution 540 – Product Status 101
YVOIRE Y-Solution 540 – Product Description 102
YVOIRE Y-Solution 720 – Product Status 102
YVOIRE Y-Solution 720 – Product Description 102
LG Chem Ltd – Ongoing Clinical Trials Overview 103
YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 104
YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 105
YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 106
LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 107
Lumina – Product Status 107
Lumina – Product Description 107
LifeSprout Inc – Ongoing Clinical Trials Overview 108
Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 109
Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 110
MT943 – Product Status 110
MT943 – Product Description 110
Neuramis Deep Lidocaine – Product Status 111
Neuramis Deep Lidocaine – Product Description 111
Neuramis Volume Lidocaine – Product Status 111
Neuramis Volume Lidocaine – Product Description 112
Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 113
VP1 Lido US – Product Status 113
VP1 Lido US – Product Description 113
Merz North America Inc – Ongoing Clinical Trials Overview 114
VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 115
Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 116
LIFT001 – Product Status 116
LIFT001 – Product Description 116
mRDX-02-17 – Product Status 117
mRDX-02-17 – Product Description 117
Mesoestetic Pharma Group SL – Ongoing Clinical Trials Overview 118
LIFT001 – Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid 119
Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 120
Restogel – 131 – Product Status 120
Restogel – 131 – Product Description 120
N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 121
Ceragenin-Infused Dermal Filler – Product Status 121
Ceragenin-Infused Dermal Filler – Product Description 121
Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 122
AntaRep – Product Status 122
AntaRep – Product Description 122
PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 123
PB&B Facial Volumizer – Product Status 123
PB&B Facial Volumizer – Product Description 123
Peptron Inc Pipeline Products & Ongoing Clinical Trials Overview 124
PLA Dermal Filler – Product Status 124
PLA Dermal Filler – Product Description 124
PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125
CosmetaLife – Product Status 125
CosmetaLife – Product Description 125
Dermal Filler – Lip – Product Status 126
Dermal Filler – Lip – Product Description 126
Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 127
GAL1906 – Product Status 127
GAL1906 – Product Description 127
GP0112 – Product Status 128
GP0112 – Product Description 128
Q-Med AB – Ongoing Clinical Trials Overview 129
GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 130
GP0112 – A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies 131
RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132
DermaPrecise Injector – Product Status 132
DermaPrecise Injector – Product Description 132
Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 133
Aesthetic Filler – Product Status 133
Aesthetic Filler – Product Description 133
SYB Filler (SF-01) – Product Status 134
SYB Filler (SF-01) – Product Description 134
Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 135
Dermal Filler – Product Status 135
Dermal Filler – Product Description 135
Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
Organic Cross-Linked HA Dermal Filler – Product Status 136
Organic Cross-Linked HA Dermal Filler – Product Description 136
QST Gel – Product Status 137
QST Gel – Product Description 137
Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 138
FreeWink – Product Status 138
FreeWink – Product Description 138
Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 139
Dermal Filler – Product Status 139
Dermal Filler – Product Description 139
SMA-001 – Product Status 140
SMA-001 – Product Description 140
Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 141
Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 142
Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 143
Atlean – Product Status 143
Atlean – Product Description 143
Ellanse Lidocaine – Product Status 144
Ellanse Lidocaine – Product Description 144
MaiLi – Product Status 144
MaiLi – Product Description 145
Perfectha G – Product Status 145
Perfectha G – Product Description 145
Perfectha Lips – Product Status 146
Perfectha Lips – Product Description 146
Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 147
Silk Protein – Tissue/Dermal Filler – Product Status 147
Silk Protein – Tissue/Dermal Filler – Product Description 147
Sofregen Medical Inc – Ongoing Clinical Trials Overview 148
Silk Protein – Tissue/Dermal Filler – A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler 149
SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 150
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Status 150
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Description 150
Sunmax FULLSGEN With Lidocaine – Product Status 151
Sunmax FULLSGEN With Lidocaine – Product Description 151
SunMax Biotechnology Co Ltd – Ongoing Clinical Trials Overview 152
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 153
Sunmax FULLSGEN With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 154
TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 155
Injectable Dermal Filler – Product Status 155
Injectable Dermal Filler – Product Description 155
Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 156
MAP Tissue Scaffold-Based Dermal Filler – Product Status 156
MAP Tissue Scaffold-Based Dermal Filler – Product Description 156
Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 157
Next Generation Dermal Filler – Product Status 157
Next Generation Dermal Filler – Product Description 157
Teosyal RHA 1 – Product Status 158
Teosyal RHA 1 – Product Description 158
Teoxane SA – Ongoing Clinical Trials Overview 159
Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 160
Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 160
Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 161
Tetrafill – Product Status 161
Tetrafill – Product Description 161
Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 162
PureVoluma – Product Status 162
PureVoluma – Product Description 162
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 163
Needle Free Injector – Product Status 163
Needle Free Injector – Product Description 163
University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 164
Collagen-Based Dermal Filler – Product Status 164
Collagen-Based Dermal Filler – Product Description 164
Glossary 168